EDBI
Venture Capital
Active
Singapore, Singapore
182
69M
131
5.52
23
0.27
33
- Stages of investment
- Areas of investment
Summary
EDBI appeared to be the VC, which was created in 1991.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Bitmain Technologies, Moderna Therapeutics, Magic Leap We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the EDBI, startups are often financed by Sequoia Capital India, Qualcomm Ventures, Accel. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Intel Capital, Sequoia Capital India. In the next rounds fund is usually obtained by New Enterprise Associates, Delphi Ventures, West Health Investment Fund.
Besides them, we counted 16 critical employees of this fund in our database.
Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. When the investment is from EDBI the average startup value is more than 1 billion dollars. This EDBI works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2018.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- SGD 285000000
- Fund raised date
- 2021-07-28
Analytics
- Total investments
- 182
- Lead investments
- 23
- Exits
- 33
- Rounds per year
- 5.52
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (62)
- Health Care (48)
- Software (39)
- Artificial Intelligence (20)
- Pharmaceutical (18) Show 192 more
- Investments by region
-
- United States (105)
- Singapore (54)
- China (5)
- Philippines (2)
- Liechtenstein (1) Show 9 more
- Peak activity year
- 2021
- Number of Unicorns
- 20
- Number of Decacorns
- 21
- Number of Minotaurs
- 10
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 657M
- Group Appearance index
- 0.96
- Avg. company exit year
- 10
- Avg. multiplicator
- 11.17
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Doctor Anywhere | 21 Dec 2022 | Information Technology, Health Care, Hospital, Unified Communications | Late Stage Venture | 38M | Central, Singapore, Singapore |
Leo Cancer Care | 11 Jun 2024 | Health Care | Late Stage Venture | England, Surrey, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.